Abstract:Background Therapeutic strategies for preventing paradoxical reperfusion injury after myocardial ischemia are limited. We tested whether central nervous system actions of leptin induce important protective effects on cardiac function and metabolism after myocardial ischemia/reperfusion (I/R) injury, the role of cardiac sympathetic innervation in mediating these effects, and whether there are major sex differences in the cardioprotective effects of chronic central nervous system leptin infusion. Methods and Results Myocardial I/R was induced by temporary ligation of the left descending coronary artery in male and female Wistar rats instrumented with intracerebroventricular cannula in the lateral ventricle. Vehicle or leptin (0.62 μg/h) infusion was started immediately after reperfusion and continued for 28 days using osmotic minipumps connected to the intracerebroventricular cannula. Cardiac function was assessed by echocardiography, ventricular pressures, and exercise performance. Intracerebroventricular leptin treatment markedly attenuated cardiac dysfunction post‐I/R as evidenced by improved ejection fraction (56.7±1.9 versus 22.6%±1.1%), maximal rate of left ventricle rise (11 680±2122 versus 5022±441 mm Hg) and exercise performance (−4.2±7.9 versus −68.2±3.8 Δ%) compared with vehicle‐treated rats. Intracerebroventricular leptin infusion reduced infarct size in females, but not males, when compared with ad‐lib fed or pair‐fed saline‐treated rats. Intracerebroventricular leptin treatment also increased cardiac NAD + /NADH content (≈10‐fold) and improved mitochondrial function when compared with vehicle treatment. Cervical ganglia denervation did not attenuate the cardiac protective effects of leptin after I/R injury. Conclusions These data indicate that leptin, via its central nervous system actions, markedly improves overall heart function and mitochondrial metabolism after I/R injury regardless of sex, effects that are largely independent of cardiac sympathetic innervation. Nonstandard Abbreviations and Acronyms β‐OHB beta‐hydroxybutyrate AMPK adenosine monophosphate‐activated protein kinase CGx cervical ganglia denervation H 2 O 2 hydrogen peroxide I/R ischemia/reperfusion OXPHOS oxidative phosphorylation ROS reactive oxygen species Clinical Perspective What Is New? Our study reveals a potent cardioprotective effects of leptin, mediated via the central nervous system, that protect the heart after ischemia/reperfusion injury. Central nervous system leptin infusion improves cardiac function in male and female rats after ischemia/reperfusion injury. The cardioprotective effect of central nervous system leptin administration is not mediated by cardiac sympathetic nerves. What Are the Clinical Implications? Understanding the mechanisms by which leptin acts on the central nervous system to regulate cardiac metabolism and function may lead to new, more effective therapeutic strategies for myocardial ischemia and heart failure. Cardiovascular disease remains the leading cause of mortality and is a major health care burden in the United States and worldwide. 1 Approximately 18.2 million Americans suffer from coronary artery disease and ≈20% of patients who experience an acute myocardial infarction (MI) develop heart failure (HF) within 5 years. 2 Reperfusion strategies are currently the primary therapies for acute MI; however, reperfusion of ischemic areas may paradoxically exacerbate MI‐associated myocardial injury, accounting for up to 50% of the final infarct size and increasing the probability of HF development. 3 Although improvements have been made with timely reperfusion strategies and advances in percutaneous coronary intervention technology, effective therapies to protect the heart against ischemia/reperfusion (I/R) injury are still limited. Our recent studies suggest that activation of brain leptin rece -Abstract Truncated-

Targeting the Brain Leptin-Melanocortin Pathway to Treat Heart Failure

Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin

Central Nervous System Actions of Leptin Improve Cardiac Function After Ischemia–Reperfusion: Roles of Sympathetic Innervation and Sex Differences

Chronic Central Nervous System Leptin Infusion Improves Cardiac Function and Metabolism after Ischemia/Reperfusion Injury

Central Actions of Leptin Induce an Atrophic Pattern and Improves Heart Function in Lean Normoleptinemic Rats via PPARβ/δ Activation

The Leptin Paradox-A Treacherous Art in Cardiac Sequelae of Obesity

What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases.

Leptin Neuroprotection in the CNS: Mechanisms and Therapeutic Potentials

Leptin Modifies the Rat Heart Performance Associated with Mitochondrial Dysfunction Independently of Its Prohypertrophic Effects

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin

Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

Novel Leptin-Cardiac TRH pathway responsible for the cardiac alterations in the Hyperleptinemic obesity

Fitness or Fatness--the Debate Continues for the Role of Leptin in Obesity-Associated Heart Dysfunction.

Leptin signaling and leptin resistance.

A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue

Autophagy Inhibition Rescues Against Leptin-Induced Cardiac Contractile Dysfunction

Leptin, the brain and energy homeostasis: From an apparently simple to a highly complex neuronal system

Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling

Leptin revisited: its mechanism of action and potential for treating diabetes

Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets

Leveraging metabolism for better outcomes in heart failure